Clinical Trial Update: Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating pegylated interferon alfa-2a in dialysis patients with acute hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED